Selectis Health, Inc. (GBCS) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
GBCS, $ (piyasa değeri 0) fiyatla Healthcare işi olan Selectis Health, Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 18 Mar 2026Selectis Health, Inc. (GBCS) Sağlık ve Boru Hattı Genel Bakışı
Selectis Health, Inc. (GBCS) is a healthcare company focused on acquiring, developing, and managing healthcare real estate, shifting from a REIT model to direct ownership and operation of facilities. The company owns twelve healthcare properties, providing both leasing and direct management services within the medical care facilities sector.
Yatırım Tezi
Selectis Health, Inc. presents a speculative investment opportunity given its transition from a REIT to an owner-operator model in the healthcare real estate sector. The company's strategic shift introduces both potential for increased profitability through direct management and operational control, but also carries significant execution risk. With a market capitalization of $0.01 billion and a negative P/E ratio of -15.73, the company's financial performance requires close monitoring. Key catalysts include successful operational improvements in its directly-managed facilities and strategic deployment of capital. The company's negative beta of -1.05 suggests an inverse correlation to market movements, which could offer diversification benefits. However, the absence of a dividend yield may deter income-focused investors.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.01 billion indicates a micro-cap company with potential for high growth but also significant risk.
- Negative P/E ratio of -15.73 reflects current unprofitability, requiring further investigation into the drivers and potential for turnaround.
- Gross margin of 20.9% indicates the percentage of revenue available to cover operating expenses.
- Profit margin of -1.9% shows the company is currently operating at a loss.
- Beta of -1.05 suggests the stock price moves inversely to the market.
Rakipler & Benzerleri
Güçlü Yönler
- Tangible asset base in healthcare real estate.
- Shift towards direct operation offers potential for higher profitability.
- Expertise in healthcare real estate market.
- Provides financing solutions to healthcare providers.
Zayıflıklar
- Small market capitalization increases volatility.
- Negative P/E ratio indicates current unprofitability.
- Transition to direct operation introduces execution risk.
- Limited diversification in healthcare properties.
Katalizörler
- Upcoming: Potential name change and charter revisions to better reflect the company's current business model.
- Ongoing: Successful transition from a REIT to a direct owner-operator model.
- Ongoing: Strategic acquisitions of additional healthcare properties.
- Ongoing: Value-add investments to improve existing facilities.
Riskler
- Potential: Changes in healthcare regulations and reimbursement rates.
- Ongoing: Increased competition from other healthcare REITs and operators.
- Potential: Economic downturn impacting occupancy rates and property values.
- Potential: Rising interest rates increasing borrowing costs.
- Ongoing: Limited financial disclosure increases information asymmetry.
Büyüme Fırsatları
- Direct Operation of Healthcare Facilities: Selectis Health's transition to directly operating its healthcare facilities presents a significant growth opportunity. By assuming direct control, the company can potentially improve operational efficiency, enhance service quality, and capture a larger share of the revenue generated by these facilities. The market for healthcare facility operations is substantial, driven by the increasing demand for senior care and specialized medical services. Successful execution of this strategy could lead to improved profitability and increased asset value.
- Strategic Acquisitions: Selectis Health can pursue strategic acquisitions of additional healthcare properties to expand its portfolio and geographic reach. The healthcare real estate market is fragmented, offering opportunities to acquire undervalued assets or properties with high growth potential. By carefully selecting and integrating new properties, Selectis Health can increase its revenue base, diversify its asset mix, and achieve economies of scale. This growth strategy requires careful due diligence and financial planning to ensure acquisitions are accretive to earnings.
- Value-Add Investments: Selectis Health can invest in upgrading and improving its existing healthcare facilities to enhance their appeal to patients and healthcare providers. This includes modernizing infrastructure, adding new amenities, and implementing technology solutions to improve patient care and operational efficiency. These value-add investments can increase occupancy rates, drive revenue growth, and enhance the overall value of the company's real estate portfolio. The market for healthcare facility improvements is driven by the need to meet evolving patient expectations and regulatory requirements.
- Expansion of Service Offerings: Selectis Health can expand its service offerings within its healthcare facilities to cater to a wider range of patient needs. This could include adding specialized medical services, rehabilitation programs, or assisted living options. By diversifying its service offerings, Selectis Health can attract more patients, increase revenue per patient, and enhance the overall value proposition of its facilities. This growth strategy requires careful market research and investment in skilled healthcare professionals.
- Healthcare Financing Solutions: Selectis Health can leverage its expertise in healthcare real estate to provide financing solutions to healthcare providers. This could include offering bridge loans, construction financing, or sale-leaseback transactions. By providing financing solutions, Selectis Health can generate additional revenue, build relationships with healthcare providers, and gain access to new investment opportunities. The market for healthcare financing is substantial, driven by the capital needs of healthcare providers to expand their operations and invest in new technologies.
Fırsatlar
- Strategic acquisitions to expand portfolio and geographic reach.
- Value-add investments to improve existing facilities.
- Expansion of service offerings within healthcare facilities.
- Leverage expertise to provide more healthcare financing solutions.
Tehditler
- Changes in healthcare regulations and reimbursement rates.
- Increased competition from other healthcare REITs and operators.
- Economic downturn impacting occupancy rates and property values.
- Rising interest rates increasing borrowing costs.
Rekabet Avantajları
- Real estate portfolio provides a tangible asset base.
- Direct operational control offers potential for higher margins.
- Expertise in healthcare real estate provides a competitive advantage.
- Financing solutions create relationships with healthcare providers.
GBCS Hakkında
Selectis Health, Inc., formerly known as Global Healthcare REIT, Inc., has evolved from its initial intent of operating as a real estate investment trust (REIT) focused on the healthcare sector. The company's strategy has shifted towards direct ownership and operation of healthcare real estate assets, moving away from the traditional REIT model of leasing properties to independent operators. As a result of this strategic shift, Selectis Health is reevaluating its corporate structure and considering a name change to better reflect its current business model. Originally, the company was named Global Casinos, Inc., which operated two gaming casinos. These casinos were divested on September 30, 2013. Simultaneously, the company acquired West Paces Ferry Healthcare REIT, Inc. (WPF) in a reverse acquisition, with WPF being the accounting acquirer. Selectis Health acquires, develops, leases, manages, and disposes of healthcare real estate. It also provides financing to healthcare providers. As of September 30, 2020, the company owned twelve healthcare properties. These properties are either leased or managed by third-party operators under triple-net operating terms or operated directly by the company. The company strategically operates facilities internally when it is advantageous and expedient to do so.
Ne Yaparlar
- Acquires healthcare real estate properties.
- Develops healthcare facilities.
- Leases healthcare properties to third-party operators.
- Manages healthcare properties directly.
- Disposes of healthcare real estate assets.
- Provides financing to healthcare providers.
İş Modeli
- Generates revenue from leasing healthcare properties to third-party operators under triple-net operating terms.
- Generates revenue from operating healthcare facilities directly.
- Generates revenue from providing financing to healthcare providers.
- Generates revenue from the disposition of healthcare real estate assets.
Sektör Bağlamı
Selectis Health, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is influenced by factors such as aging demographics, healthcare regulations, and reimbursement rates. The competitive landscape includes REITs and healthcare operators. Selectis Health's shift towards direct operation differentiates it from traditional healthcare REITs, potentially offering higher returns but also increased operational complexity. The industry is experiencing growth due to increasing demand for healthcare services, but faces challenges related to cost containment and regulatory compliance.
Kilit Müşteriler
- Third-party healthcare operators who lease properties from Selectis Health.
- Patients who receive care at Selectis Health's directly-operated facilities.
- Healthcare providers who receive financing from Selectis Health.
Finansallar
Grafik & Bilgi
Selectis Health, Inc. (GBCS) hisse senedi fiyatı: Price data unavailable
Son Haberler
GBCS için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
GBCS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
GBCS için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, GBCS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Adam Desmond
CEO
Adam Desmond currently serves as the CEO of Selectis Health, Inc. His responsibilities include overseeing the company's strategic direction, operational performance, and financial management. Prior to his role at Selectis Health, details regarding his specific career history, education, and previous roles are not available. However, as CEO, he is responsible for guiding the company through its transition from a REIT to a direct owner-operator model.
Sicil: As CEO, Adam Desmond is currently leading Selectis Health through a strategic shift from a healthcare REIT to direct ownership and operation of healthcare facilities. Specific achievements and milestones under his leadership are not available, but his focus is on improving operational efficiency, enhancing service quality, and driving revenue growth. He is also responsible for managing the company's real estate portfolio and providing financing solutions to healthcare providers.
GBCS OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Selectis Health, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors, and trading activity may be thin and sporadic. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. These stocks are generally considered highly speculative and suitable only for investors with a high risk tolerance.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Potential for fraud or manipulation due to lack of regulatory oversight.
- Higher risk of delisting or going out of business.
- Limited analyst coverage and investor awareness.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's capital structure and debt levels.
- Review the company's OTC Markets profile and disclosure statements.
- Check for any regulatory actions or legal proceedings against the company.
- Consult with a qualified financial advisor before investing.
- Company has been in operation for several years.
- Owns tangible assets in the form of healthcare real estate.
- Provides financing solutions to healthcare providers.
- Shift towards direct operation of healthcare facilities suggests a strategic focus.
Yatırımcılar Selectis Health, Inc. (GBCS) Hakkında Ne Soruyor
GBCS için değerlendirilmesi gereken temel faktörler nelerdir?
Selectis Health, Inc. (GBCS) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Temel güçlü yan: Tangible asset base in healthcare real estate.. İzlenmesi gereken birincil risk: Potential: Changes in healthcare regulations and reimbursement rates.. Bu bir finansal tavsiye değildir.
GBCS MoonshotScore'u nedir?
GBCS şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
GBCS verileri ne sıklıkla güncellenir?
GBCS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler GBCS hakkında ne diyor?
GBCS için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
GBCS'a yatırım yapmanın riskleri nelerdir?
GBCS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in healthcare regulations and reimbursement rates.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
GBCS'ın P/E oranı nedir?
GBCS için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için GBCS'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
GBCS aşırı değerli mi, yoksa düşük değerli mi?
Selectis Health, Inc. (GBCS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
GBCS'ın temettü verimi nedir?
Selectis Health, Inc. (GBCS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available sources as of 2026-03-18.
- OTC market data may be limited and less reliable than data for exchange-listed companies.
- AI analysis is pending and may provide additional insights in the future.